Fintel reports that on January 22, 2025, Citigroup downgraded their outlook for Ambev S.A. - Depositary Receipt () (NYSE:ABEV) from Buy to Neutral. Analyst Price Forecast Suggests 43.02% Upside As of ...

Ambev SA engages in the production, distribution, and sale of beverages. Its products include beer, carbonated soft drinks, and other non-alcoholic and non-carbonated products. It operates through ...

Ambev S.A. offers strong revenue growth, high operating margins, and a solid balance sheet with minimal debt, making it a compelling investment despite Brazil's economic challenges. ABEV is ...

BofA downgraded Ambev (ABEV) to Neutral from Buy with a price target of $2.10, down from $2.80. The firm noted that Ambev had a successful turnaround over the last five years, driven by “a very ...

Barclays analyst Benjamin Theurer lowered the firm’s price target on Ambev (ABEV) to $2 from $2.50 and keeps an Equal Weight rating on the shares. Entering 2025, the firm is more optimistic ...